June 19, 2020 / 12:34 PM / 22 days ago

BRIEF-Regeneron's Dupixent Included In List Of Overseas Approved Drugs That Meet Urgent Clinical in China

June 19 (Reuters) - Regeneron Pharmaceuticals Inc:

* DUPIXENT® (DUPILUMAB) APPROVED IN CHINA FOR ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

* REGENERON PHARMACEUTICALS - DUPIXENT INCLUDED IN LIST OF OVERSEAS APPROVED DRUGS THAT MEET URGENT CLINICAL NEED IN CHINA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below